James W. Vardiman
- Hematology top 0.01%
- Acute Myeloid Leukemia Research 64
- Chronic Myeloid Leukemia Treatments 23
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research 28
- Myeloproliferative Neoplasms: Diagnosis and Treatment 26
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 28
- Rheumatology top 0.2%
- Eosinophilic Disorders and Syndromes 14
-
- Acute Lymphoblastic Leukemia research 25
-
- Retinoids in leukemia and cellular processes 12
- Co-authors
- Clara D. BloomfieldMichelle M. Le BeauNancy L. HarrisDaniel A. ArberMichael J. BorowitzRichard D. BrunningAttilio OraziRobert P. Hasserjian
- Partner nations
- United StatesGermanyItaly
In The Last Decade
James W. Vardiman
117 papers receiving 21.7k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Hematology 14.5k
- Genetics 8.9k
- Pathology and Forensic Medicine 3.8k
- Rheumatology 2.8k
- Public Health, Environmental and Occupational Health 4.0k
Countries citing papers authored by James W. Vardiman
This map shows the geographic impact of James W. Vardiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Vardiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Vardiman more than expected).
Fields of papers citing papers by James W. Vardiman
This network shows the impact of papers produced by James W. Vardiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Vardiman. The network helps show where James W. Vardiman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James W. Vardiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiabreakdown → | 2016 | 6033 |
| 2 | 2015 | 40 | |
| 3 | 2012 | 90 | |
| 4 | 2009 | 144 | |
| 5 | 2009 | 50 | |
| 6 | 2009 | 165 | |
| 7 | 2008 | 5 | |
| 8 | Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelbreakdown → | 2007 | 604 |
| 9 | 2007 | 28 | |
| 10 | 2006 | 10 | |
| 11 | 2004 | 64 | |
| 12 | 2004 | 114 | |
| 13 | 2003 | 1 | |
| 14 | Diagnostic criteria and classification of mastocytosis: a consensus proposalbreakdown → | 2001 | 738 |
| 15 | 2000 | 296 | |
| 16 | 1995 | 24 | |
| 17 | 1993 | 13 | |
| 18 | 1991 | 21 | |
| 19 | 1990 | 95 | |
| 20 | 1988 | 2 |
About James W. Vardiman
James W. Vardiman is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 118 papers that have together received 22.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (64 papers), Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (28 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Acute Lymphoblastic Leukemia research (25 papers), Chronic Myeloid Leukemia Treatments (23 papers), Eosinophilic Disorders and Syndromes (14 papers) and Retinoids in leukemia and cellular processes (12 papers). The work is most often cited by research in Hematology (14.5k citations), Genetics (8.9k citations) and Pathology and Forensic Medicine (3.8k citations). James W. Vardiman has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Clara D. Bloomfield, Michelle M. Le Beau, Nancy L. Harris, Daniel A. Arber, Michael J. Borowitz, Richard D. Brunning, Attilio Orazi, Robert P. Hasserjian, Jürgen Thiele and Mario Cazzola. Their work appears in journals such as Blood, Cancer, American Journal of Clinical Pathology, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.